News & Updates

Some patients with nonsmall-cell lung cancer (NSCLC) have somatic DNA methyltransferase 3A (DNMT3A) mutations, which are associated with a reduced DNMT3A expression and a favourable immunophenotype, reveals a study.

In the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC), the combination of cemiplimab plus chemotherapy continued to provide superior benefits compared with chemotherapy alone, according to 5-year data from the phase III EMPOWER-Lung part 2 trial.

People with a history of COVID-19 appear to have reduced sleep quality, as reported in a study.

Certain plant-based foods and probiotic drinks appear to be associated with reduced prevalence of allergic asthma among young Chinese adults in Singapore, according to a study.

New drug applications approved by US FDA as of 16-30 September 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Treatment with colchicine does not appear to improve functional capacity, respiratory function, or inflammatory markers in adults with long COVID, as shown in a study.

Treatment with oral morphine falls short of improving breathlessness due to cardiorespiratory conditions, as shown in a study.

In the treatment of patients with mild-to-moderate hypercapnic exacerbations of chronic obstructive pulmonary disease (COPD), the EzPAP positive airway pressure device works better than noninvasive ventilation at improving oxygen saturation levels and correcting respiratory acidosis, as shown in a study.

A slow-tempo music intervention falls short of reducing the duration and severity of delirium in older patients on mechanical ventilation, according to a study.